Xcout IntelGenome Medical Holding Co
Genome Medical provides telehealth-enabled genetic services, offering expert genetic counseling, genetic test ordering, and clinical trial matching for patients and families. The company also partners with healthcare providers, health systems, and life sciences organizations to expand access to genetics care and improve rare disease diagnosis and management.
Subscribe to see Genome Medical Holding Co’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Genome Medical Holding Co at a glance
Genome Medical Holding Co is a healthcare & biotechnology company headquartered in United States. It has raised at least $98.6M across the 3 funding rounds on record. Its most recent funding round raised $75.3M in September 2024. Xcout tracks 7 named people at Genome Medical Holding Co, including Jill Davies (Chief Executive Officer).
Genome Medical Holding Co leadership
- Jill DaviesChief Executive Officer
- Elizabeth MorenoExecutive Officer
- Jill DaviesExecutive Officer
- Mark SylvesterExecutive Officer
- Alex ParkerDirector
- Russell GlassDirector
1 more named person on record for Genome Medical Holding Co, with roles, board committees and tenure — see the full roster →
Genome Medical Holding Co funding rounds
At least $98.6M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $75.3M | — | |
| SEC Form D filing | $23M | — | |
| SEC Form D filing | $223,200 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Genome Medical Holding Co competitors
A few of Genome Medical Holding Co's closest competitors — see the full list of competitors and alternatives →
gMendel is a medical technology company founded in 2020 that develops an AI-powered, cloud-based platform combining genomics with artificial intelligence. The company provides decision support software designed to enable faster, more accurate, and scalable diagnosis of genetic disorders.
Inflection Medicine provides a genomic care platform that integrates genomic data into clinical care for critically ill newborns, children, and patients across various specialties. The platform manages sequencing processes, synthesizes genetic and clinical data, provides evidence-based guidance, and creates care plans to help clinicians detect conditions early and coordinate treatment.
SeqOne Genomics is a certified medical device and technology company providing a smart genomics platform that leverages artificial intelligence to support genomic data analysis.
Clear Genetics is a digital-health company that provides genetic counseling and genetic-testing support, primarily through a technology-enabled platform. It serves patients and healthcare providers seeking access to hereditary-risk assessment and related genetic services.
Probably Genetic is a healthcare technology company focused on helping identify rare genetic diseases through genetic testing and clinical software. It serves patients with undiagnosed conditions and the healthcare professionals involved in their diagnosis and care.
Get Genome Medical Holding Co's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Genome Medical Holding Co in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access